These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Additive genetic effect of GCKR, G6PC2, and SLC30A8 variants on fasting glucose levels and risk of type 2 diabetes. Chen G; Shriner D; Zhang J; Zhou J; Adikaram P; Doumatey AP; Bentley AR; Adeyemo A; Rotimi CN PLoS One; 2022; 17(6):e0269378. PubMed ID: 35657990 [TBL] [Abstract][Full Text] [Related]
26. Absence of birth-weight lowering effect of ADCY5 and near CCNL, but association of impaired glucose-insulin homeostasis with ADCY5 in Asian Indians. Vasan SK; Neville MJ; Antonisamy B; Samuel P; Fall CH; Geethanjali FS; Thomas N; Raghupathy P; Brismar K; Karpe F PLoS One; 2011; 6(6):e21331. PubMed ID: 21712988 [TBL] [Abstract][Full Text] [Related]
27. Effects of common genetic variants associated with type 2 diabetes and glycemic traits on α- and β-cell function and insulin action in humans. Jonsson A; Ladenvall C; Ahluwalia TS; Kravic J; Krus U; Taneera J; Isomaa B; Tuomi T; Renström E; Groop L; Lyssenko V Diabetes; 2013 Aug; 62(8):2978-83. PubMed ID: 23557703 [TBL] [Abstract][Full Text] [Related]
28. Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism. Walford GA; Green T; Neale B; Isakova T; Rotter JI; Grant SF; Fox CS; Pankow JS; Wilson JG; Meigs JB; Siscovick DS; Bowden DW; Daly MJ; Florez JC Diabetologia; 2012 Feb; 55(2):331-9. PubMed ID: 22038522 [TBL] [Abstract][Full Text] [Related]
29. The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemia. Heni M; Ketterer C; Hart LM; Ranta F; van Haeften TW; Eekhoff EM; Dekker JM; Boomsma DI; Nijpels G; Kramer MH; Diamant M; Simonis-Bik AM; Heine RJ; de Geus EJ; Schäfer SA; Machicao F; Ullrich S; Thamer C; Stefan N; Staiger H; Häring HU; Fritsche A J Clin Endocrinol Metab; 2010 Dec; 95(12):E479-84. PubMed ID: 20826583 [TBL] [Abstract][Full Text] [Related]
30. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Kitabchi AE; Temprosa M; Knowler WC; Kahn SE; Fowler SE; Haffner SM; Andres R; Saudek C; Edelstein SL; Arakaki R; Murphy MB; Shamoon H; Diabetes; 2005 Aug; 54(8):2404-14. PubMed ID: 16046308 [TBL] [Abstract][Full Text] [Related]
31. Association of genetic Loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children. Barker A; Sharp SJ; Timpson NJ; Bouatia-Naji N; Warrington NM; Kanoni S; Beilin LJ; Brage S; Deloukas P; Evans DM; Grontved A; Hassanali N; Lawlor DA; Lecoeur C; Loos RJ; Lye SJ; McCarthy MI; Mori TA; Ndiaye NC; Newnham JP; Ntalla I; Pennell CE; St Pourcain B; Prokopenko I; Ring SM; Sattar N; Visvikis-Siest S; Dedoussis GV; Palmer LJ; Froguel P; Smith GD; Ekelund U; Wareham NJ; Langenberg C Diabetes; 2011 Jun; 60(6):1805-12. PubMed ID: 21515849 [TBL] [Abstract][Full Text] [Related]
32. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P; Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336 [TBL] [Abstract][Full Text] [Related]
33. Alcohol consumption and diabetes risk in the Diabetes Prevention Program. Crandall JP; Polsky S; Howard AA; Perreault L; Bray GA; Barrett-Connor E; Brown-Friday J; Whittington T; Foo S; Ma Y; Edelstein SL; Am J Clin Nutr; 2009 Sep; 90(3):595-601. PubMed ID: 19640960 [TBL] [Abstract][Full Text] [Related]
34. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. Florez JC; Jablonski KA; Bayley N; Pollin TI; de Bakker PI; Shuldiner AR; Knowler WC; Nathan DM; Altshuler D; N Engl J Med; 2006 Jul; 355(3):241-50. PubMed ID: 16855264 [TBL] [Abstract][Full Text] [Related]
35. Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture using Genomics and Epidemiology (PAGE) consortium. Bien SA; Pankow JS; Haessler J; Lu Y; Pankratz N; Rohde RR; Tamuno A; Carlson CS; Schumacher FR; Bůžková P; Daviglus ML; Lim U; Fornage M; Fernandez-Rhodes L; Avilés-Santa L; Buyske S; Gross MD; Graff M; Isasi CR; Kuller LH; Manson JE; Matise TC; Prentice RL; Wilkens LR; Yoneyama S; Loos RJF; Hindorff LA; Le Marchand L; North KE; Haiman CA; Peters U; Kooperberg C Diabetologia; 2017 Dec; 60(12):2384-2398. PubMed ID: 28905132 [TBL] [Abstract][Full Text] [Related]
36. The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program. Moore AF; Jablonski KA; Mason CC; McAteer JB; Arakaki RF; Goldstein BJ; Kahn SE; Kitabchi AE; Hanson RL; Knowler WC; Florez JC; J Clin Endocrinol Metab; 2009 Feb; 94(2):449-55. PubMed ID: 19017751 [TBL] [Abstract][Full Text] [Related]
37. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Huopio H; Cederberg H; Vangipurapu J; Hakkarainen H; Pääkkönen M; Kuulasmaa T; Heinonen S; Laakso M Eur J Endocrinol; 2013 Sep; 169(3):291-7. PubMed ID: 23761423 [TBL] [Abstract][Full Text] [Related]
38. Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. Jablonski KA; McAteer JB; de Bakker PI; Franks PW; Pollin TI; Hanson RL; Saxena R; Fowler S; Shuldiner AR; Knowler WC; Altshuler D; Florez JC; Diabetes; 2010 Oct; 59(10):2672-81. PubMed ID: 20682687 [TBL] [Abstract][Full Text] [Related]
39. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Florez JC; Jablonski KA; Kahn SE; Franks PW; Dabelea D; Hamman RF; Knowler WC; Nathan DM; Altshuler D Diabetes; 2007 Feb; 56(2):531-6. PubMed ID: 17259403 [TBL] [Abstract][Full Text] [Related]
40. Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program. Pollin TI; Isakova T; Jablonski KA; de Bakker PI; Taylor A; McAteer J; Pan Q; Horton ES; Delahanty LM; Altshuler D; Shuldiner AR; Goldberg RB; Florez JC; Franks PW; PLoS Genet; 2012; 8(8):e1002895. PubMed ID: 22951888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]